U.S. trade rep says no return to TPP deal and wants bilateral deals in Asia | Reuters
HANOI U.S. Trade Representative Robert Lighthizer said on Sunday that the United States would not return to the Trans-Pacific Partnership trade deal after 11 remaining countries earlier agreed to look at how they could move ahead without it.He said the United States favoured bilateral over multilateral trade deals and he expected a series of agreements in the region, where he is attending a meeting of ministers from Asia-Pacific Economic Cooperation (APEC) countries.
"The United States pulled out of the TPP and it's not going to change that decision. That does not mean we will not engage in this region," Lighthizer told a news conference in Hanoi, Vietnam.
"The president made a decision, that I certainly agree with, that bilateral negotiations are better for the United States than multilateral negotiations."
Asked why the United States was against using language opposing protectionism, he said it favoured free trade, but would defend against unfair trade. (Reporting by Mai Nguyen; Writing by Matthew Tostevin; Editing by Simon Cameron-Moore)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Uday Sampath Kumar (Reuters) - Target Corp reported a 17.2% rise in comparable sales for the holiday season on Wednesday as its online sales more than doubled, thanks to faster deliveries and higher demand for home goods, electronics and beauty products.
By Medha Singh and Devik Jain (Reuters) - The S&P 500 and the Nasdaq rose in choppy trading on Wednesday as Intel shares jumped thanks to a change in management while broader sentiment was muted after a recent run to record highs. Intel said it would replace Chief Executive Officer Bob Swan with VMware Inc CEO Pat Gelsinger next month
By Danny Ramos LA PAZ (Reuters) - The Bolivian government said on Wednesday it had signed a contract with India's Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine. President Luis Arce said that combined with a recent deal to buy 5.2 million Sputnik V vaccine doses from Russia, Bolivia now expected to be able to inoculate all of its vaccinable population. Both vaccines require two doses to be given, meaning they would be used to inoculate a total of 5.1 million people from Bolivia's 11.51 million-strong population.